Austar Lifesciences Limited
HKEX:6118.HK
0.62 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 163.765 | 133.624 | 198.447 | 177.949 | 191.084 | 196.459 | 309.32 | 286.352 | 393.383 | 382.624 | 139.712 |
| Short Term Investments
| 10 | 14.505 | 21.294 | 0.162 | 0.209 | 0.206 | 0.203 | 35.347 | 0 | 0 | 25.018 |
| Cash and Short Term Investments
| 173.765 | 148.129 | 219.741 | 178.111 | 191.293 | 196.665 | 309.523 | 321.699 | 393.383 | 382.624 | 164.73 |
| Net Receivables
| 994.689 | 1,000.406 | 672.83 | 515.496 | 433.955 | 409.006 | 325.105 | 339.787 | 326.37 | 304.62 | 260.777 |
| Inventory
| 243.16 | 388.106 | 423.261 | 209.24 | 163.517 | 131.885 | 77.12 | 90.623 | 74.92 | 69.113 | 74.55 |
| Other Current Assets
| 162.205 | 264.366 | 347.409 | 186.436 | 139.407 | 155.305 | 43.208 | 42.455 | 72.448 | 43.051 | 37.417 |
| Total Current Assets
| 1,573.819 | 1,801.007 | 1,663.241 | 1,089.283 | 928.172 | 892.861 | 754.956 | 794.564 | 867.121 | 799.408 | 537.474 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 382.022 | 433.609 | 311.805 | 185.925 | 145.431 | 50.569 | 41.868 | 42.222 | 43.557 | 38.545 | 33.103 |
| Goodwill
| 0 | 0 | 0 | 1.57 | 4.645 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 104.301 | 55.865 | 21.113 | 21.889 | 21.608 | 63.224 | 12.119 | 10.412 | 8.066 | 7.738 | 7.673 |
| Goodwill and Intangible Assets
| 104.301 | 55.865 | 21.113 | 23.459 | 26.253 | 63.224 | 12.119 | 10.412 | 8.066 | 7.738 | 7.673 |
| Long Term Investments
| 82.11 | 85.499 | 39.703 | 62.94 | 57.509 | 47.728 | 39.608 | 34.586 | 18.24 | 18.031 | 19.766 |
| Tax Assets
| 16.72 | 12.783 | 8.915 | 7.047 | 6.558 | 7.264 | 8.257 | 7.887 | 7.706 | 5.668 | 8.837 |
| Other Non-Current Assets
| 0 | -12.783 | -8.915 | -7.047 | -6.558 | -7.264 | -8.257 | -7.887 | -7.706 | -5.668 | -8.837 |
| Total Non-Current Assets
| 585.153 | 574.973 | 372.621 | 272.324 | 229.193 | 161.521 | 93.595 | 87.22 | 69.863 | 64.314 | 60.542 |
| Total Assets
| 2,158.972 | 2,388.763 | 2,044.777 | 1,378.844 | 1,174.322 | 1,071.37 | 881.567 | 914.776 | 960.985 | 869.39 | 606.853 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 405.927 | 426.204 | 352.346 | 296.922 | 261.748 | 240.941 | 164.135 | 193.319 | 187.373 | 117.23 | 121.722 |
| Short Term Debt
| 333.213 | 233.604 | 66.062 | 44.128 | 33.459 | 25.888 | 47.207 | 20 | 35 | 35 | 20 |
| Tax Payables
| 10.629 | 22.84 | 19.126 | 15.899 | 4.417 | 13.83 | 6.591 | 1.177 | 2.979 | 7.985 | 21.272 |
| Deferred Revenue
| -13.38 | -233.604 | -66.062 | -44.128 | -33.459 | -25.888 | -47.207 | -20 | -35 | -35 | -20 |
| Other Current Liabilities
| 35.371 | 484.517 | 412.378 | 195.941 | 105.874 | 81.215 | 56.801 | -34.325 | 15.539 | 62.218 | 201.483 |
| Total Current Liabilities
| 1,177.687 | 1,359.765 | 1,136.196 | 805.684 | 633.787 | 576.927 | 391.662 | 353.49 | 393.264 | 304.663 | 466.199 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 162.986 | 40.067 | 54.271 | 32.337 | 24.988 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0.341 | 0.544 | 0.746 | 0.452 | 1.972 | 3.511 | 0.555 | 0.6 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 37.843 | 37.74 | 30.254 | 15.797 | 10.95 | 8.009 | 8.963 | 14.571 | 16.737 | 15.671 | 12.279 |
| Other Non-Current Liabilities
| 4.642 | -38.284 | -31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 205.812 | 40.067 | 54.271 | 48.586 | 37.91 | 11.52 | 9.518 | 15.171 | 16.737 | 15.671 | 12.279 |
| Total Liabilities
| 1,383.499 | 1,505.182 | 1,256.357 | 854.27 | 671.697 | 588.447 | 401.18 | 368.661 | 410.001 | 320.334 | 478.478 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 4.071 | 4.071 | 4.071 | 4.071 | 4.071 | 4.071 | 4.071 | 4.071 | 4.071 | 4.071 | 0 |
| Retained Earnings
| 385.294 | 498.767 | 411.306 | 134.006 | 100.906 | 92.815 | 98.713 | 152.798 | 171.468 | 185.339 | 126.135 |
| Accumulated Other Comprehensive Income/Loss
| 383.648 | 54.552 | 27.048 | 35.663 | 45.401 | 39.919 | 31.498 | 45.086 | 31.285 | 15.486 | 2.239 |
| Other Total Stockholders Equity
| 0 | 339.554 | 344.159 | 344.159 | 344.159 | 344.159 | 344.159 | 344.159 | 344.159 | 344.159 | 0 |
| Total Shareholders Equity
| 773.013 | 896.944 | 786.584 | 517.899 | 494.537 | 480.964 | 478.441 | 546.114 | 550.983 | 549.055 | 128.374 |
| Total Equity
| 775.473 | 883.581 | 788.42 | 524.574 | 502.625 | 482.923 | 480.387 | 546.115 | 550.984 | 549.056 | 128.375 |
| Total Liabilities & Shareholders Equity
| 2,158.972 | 2,388.763 | 2,044.777 | 1,378.844 | 1,174.322 | 1,071.37 | 881.567 | 914.776 | 960.985 | 869.39 | 606.853 |